Bis-Enoxacin Blocks Rat Alveolar Bone Resorption from Experimental Periodontitis
نویسندگان
چکیده
منابع مشابه
Bis-Enoxacin Blocks Rat Alveolar Bone Resorption from Experimental Periodontitis
Periodontal diseases are multifactorial, caused by polymicrobial subgingival pathogens, including Porphyromonas gingivalis, Treponema denticola, and Tannerella forsythia. Chronic periodontal infection results in inflammation, destruction of connective tissues, periodontal ligament, and alveolar bone resorption, and ultimately tooth loss. Enoxacin and a bisphosphonate derivative of enoxacin (bis...
متن کاملEffect of sodium alendronate on alveolar bone resorption in experimental periodontitis in rats.
BACKGROUND Bisphosphonates are potent inhibitors of bone resorption and were shown to inhibit bone resorption in experimental periodontitis by unknown mechanisms. We studied the effect of the aminobisphosphonate sodium alendronate (SA) in experimental periodontitis. Wistar rats were subjected to ligature placement around the second upper left molars. METHODS Animals were treated with SA 0.01 ...
متن کاملInfluences of Fucoxanthin on Alveolar Bone Resorption in Induced Periodontitis in Rat Molars
The aim of this study was to evaluate the effects of systemic fucoxanthin treatment on alveolar bone resorption in rats with periodontitis. Thirty rats were divided into control, experimental periodontitis (EP), and experimental periodontitis-fucoxanthin (EP-FUCO) groups. Periodontitis was induced by ligature for four weeks. After removal of the ligature, the rats in the EP-FUCO group were trea...
متن کاملDisodium chlodronate prevents bone resorption in experimental periodontitis in rats.
BACKGROUND Periodontitis is a chronic disease characterized by alveolar bone loss and inflammatory changes. We studied the effect of disodium chlodronate (CD), a bisphosphonate used in metastatic and metabolic bone disease as a bone resorbing drug, in an experimental periodontitis model (EPD) focusing on anti-resorptive and anti-inflammatory parameters. METHODS A nylon thread ligature was pla...
متن کاملRANKL inhibition through osteoprotegerin blocks bone loss in experimental periodontitis.
BACKGROUND Prevention of alveolar bone destruction is a clinical challenge in periodontal disease treatment. The receptor activator of nuclear factor-kappa B ligand (RANKL) inhibitor osteoprotegerin (OPG) inhibits osteoclastogenesis and suppresses bone resorption. METHODS To study the effects of RANKL inhibition on alveolar bone loss, an experimental ligature-induced model of periodontitis wa...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: PLoS ONE
سال: 2014
ISSN: 1932-6203
DOI: 10.1371/journal.pone.0092119